Dipal Doshi
President and CEO at Entrada Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Entrada Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Azenta Inc. January 28, 202682.6%
-
Entrada Therapeutics Inc. June 11, 202598.5%
-
Azenta Inc. January 30, 202598.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Entrada Therapeutics Inc. | Shares withheld for tax | −8,724 | $7.14 | $62,289 |
| Mar 3, 2026 | Entrada Therapeutics Inc. | Shares withheld for tax | −19,181 | $11.76 | $225,569 |
| Mar 2, 2026 | Entrada Therapeutics Inc. | Shares withheld for tax | −9,869 | $11.66 | $115,073 |
| Mar 1, 2026 | Entrada Therapeutics Inc. | Grant or award | +139,400 | — | — |
| Feb 5, 2026 | Azenta Inc. | Grant or award | +5,663 | $27.85 | $157,715 |
| Sep 2, 2025 | Entrada Therapeutics Inc. | Shares withheld for tax | −8,723 | $5.43 | $47,366 |
| Mar 3, 2025 | Entrada Therapeutics Inc. | Shares withheld for tax | −17,566 | $11.68 | $205,171 |
| Mar 1, 2025 | Entrada Therapeutics Inc. | Grant or award | +116,200 | — | — |
| Feb 7, 2025 | Azenta Inc. | Grant or award | +4,040 | $52.32 | $211,373 |
| Sep 5, 2024 | Entrada Therapeutics Inc. | Shares withheld for tax | −826 | $15.13 | $12,497 |
| Sep 4, 2024 | Entrada Therapeutics Inc. | Shares withheld for tax | −4,744 | $15.42 | $73,152 |
| Sep 3, 2024 | Entrada Therapeutics Inc. | Shares withheld for tax | −2,328 | $15.76 | $36,689 |
| Sep 3, 2024 | Entrada Therapeutics Inc. | Shares withheld for tax | −752 | $16.93 | $12,731 |
| Sep 3, 2024 | Entrada Therapeutics Inc. | Shares withheld for tax | −72 | $17.70 | $1,274 |
| Jul 15, 2024 | Entrada Therapeutics Inc. | Open-market sale | −1,600 | $17.81 | $28,496 |
Questions about Dipal Doshi
What boards is Dipal Doshi on?
Dipal Doshi sits on the boards of Azenta Inc. and Entrada Therapeutics Inc.
What company is Dipal Doshi the CEO of?
Dipal Doshi is President and CEO of Entrada Therapeutics Inc.
How long has Dipal Doshi served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.